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Kappa Opioid Regulation of Stress-Related Behavior
Abstract

Erin Harshberger
McNair Scholar

Glenn Valdez, Ph.D
Faculty Mentor

Anxiety disorders affect roughly 40 million
American adults in a given year. Those suffering
from anxiety disorders often experience additional
stress-linked illnesses, such as depression. Previous
research has shown that stress exposure increases
levels of the endogenous neuropeptide dynorphin,
which the kappa opioid system is selectively activated by. This study examined the role of the
kappa opioid system in regulating stress-related
behavior using the elevated plus-maze. Behavioral
stress responses were examined in male Wistar
rats following i.p. administration of opioid agonist U-50,488 (0 or 10 mg/kg). Subjects were
pretreated with the kappa opioid antagonist norbinaltorphimine (nor-BNI) 24 hours prior to testing in the elevated plus-maze (0 or 20 mg/kg).
Injections of 10 mg/kg U-50,488 significantly
decreased percent open arm time compared to controls, an effect reversed by pretreatment with 20
mg/kg nor-BNI (F(1,44) = 6.10, p < 0.05).
A main effect of nor-BNI was found on the total
number of arm entries (F(1,44) = 11.73, p <
0.05). Further analysis revealed that pretreatment with nor-BNI led to an increased number
of arm entries in rats injected with U-50,488.
The nor-BNI sensitivity of the behavioral responses suggests an activation of the kappa opioid
receptors by a stress-induced release of dynorphin.
The results indicate a relationship between kappa
opioid receptors and stress-related behaviors and
illustrate the potential therapeutic value of targeting the kappa opioid system in the treatment of
anxiety and other stress-related disorders.

Introduction
Anxiety disorders affect roughly 40 million American adults (about 18% of the
US population) in a given year (Kessler,
2005). In addition, those suffering from
an anxiety disorder often experience comorbidity with other stress-linked mental
illnesses such as depression and alcohol
and drug abuse, suggesting that stress is a
critical component in the development of
these disorders.
A classic definition of stress is any response to demands, usually noxious, placed
on the body (Selye, 1936). An alternate
definition describes stress as any alterations
in the psychological homeostatic process
(Burchfield, 1979). Although exposure to
certain levels of stress is a normal occurrence in everyday life, chronic stress can
lead to the development of psychiatric
disorders, such as anxiety and depression
(Hennessy & Levine, 1979). Stress has
been found to increase the release of several endogenous neurochemicals, including dynorphin (Nabeshima, et al., 1992), a
neuropeptide that binds with high affinity
to kappa opioid receptors (Chavkin, et al.,
1982).
Recent evidence suggests the involvement of the dynorphin/kappa opioid
receptor (KOR) system in mediating the
stress responses. McLaughlin, et al. (2003)
investigated the involvement of the kappa
opioid system in the stress response by examining the behavior of mice subjected
to forced swim stress. Mice lacking the
prodynorphin gene showed a significant
reduction in stress-induced immobility, an
indication of depression-like behavior, in
the forced swim test. Similar results were
found in mice pretreated with the kappa
opioid antagonist nor-binaltorphimine
(nor-BNI). In addition, tests using social
defeat stress (SDS) found prodynorphin
knockout mice and those that received norBNI pretreatment to spend significantly
less time in socially defeated, immobile
postures (McLaughlin, et al., 2006). Taken
together, these results implicate a role of
the dynorphin/KOR system in behavioral
responses to stress.
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The dynorphin/KOR system has also
been examined in stress-related reinstatement of drug seeking (Beardsley, et al.,
2005; Valdez, et al., 2007). The KOR antagonist JDTic was found to block stressinduced reinstatement of cocaine seeking.
It also decreased time spent immobile
in the forced swim test, suggesting the
antistress potential of KOR antagonists
(Beardsley, et al., 2005). Another study
found that the KOR agonists spiradoline
and enadoline led to reinstatement of
cocaine-seeking behavior in squirrel monkeys, but this effect was not reversed by the
antagonist nor-BNI (Valdez, et al., 2007).
These results suggest a possible mediation
of stress-related behavior by a subpopulation of kappa opioid receptors. However,
blockade of corticotropin releasing factor
and norephinephrine, two brain systems
also thought to be mediators of the stress
response (Koob, 1999), prevented spiradoline-induced reinstatement. Although
these findings suggest that brain kappa
opioid system is involved in the regulation
of stress-related behaviors, additional research is needed to understand the role of
the KOR system.
The purpose of this study was to examine the role of the kappa opioid system in
regulating behavioral responses to stress.
The effects of U-50,488 on stress-related
behavior were examined in the elevated
plus-maze, a classic animal model of anxiety (Pellow & File, 1986). In addition,
the effects of the selective antagonist norBNI administered as a pretreatment to
U-50,488 were examined. The results of
this experiment reveal the ability of norBNI to reduce stress-induced increases
in anxiety-like behavior, suggesting that
kappa opioid mechanisms are involved
in the regulation of behaviors induced by
external stressors.

stress associated with the experimental
procedure. Animals were maintained on
a 12-hr reverse light/dark cycle (lights on
at 10:00 PM).
Apparatus
The elevated plus-maze (Med Associates, St. Albans, VT) measures unconditioned approach-avoidance behavior during exploration of a novel environment in
rats (Pellow & File, 1986). The apparatus
was made of dark Plexiglas and consisted
of four arms (50 cm long X 10 cm wide).
The two enclosed arms had 40 cm high
dark walls, whereas the two open arms
had 0.5 cm high ledges. The maze was
elevated to a height of 50 cm.
Drugs
U50-488 [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclo-hexyl] benzeneacetamide; Tocris Biosciences, Ellisville, MO] and nor-binaltorphimine
(nor-BNI; Tocris Biosciences, Ellisville,
MO) were dissolved in 0.9% saline solution for i.p. injections.
Behavioral testing procedure
Rats received intraperitoneal (i.p.) injections of nor-BNI (0 or 20 mg/kg) at
least 24 hours prior to testing in the elevated plus-maze. This pretreatment period was chosen because previous research
has shown that nor-BNI is most selective
for kappa opioid receptors at 24 hours as
opposed to earlier time points (Endoh, et

al., 1992). On the day of testing, rats were
further divided into groups receiving different doses of U-50,488 (0 or 10 mg/kg).
Injections of U-50,488 took place 10 minutes prior to testing in the elevated plusmaze.
To examine anxiety-like behavior and
general motor activity, rats were placed
individually onto the center of the apparatus facing a closed arm. The time spent
on and entries onto each arm were recorded automatically by photocell beams
and monitored by a computer for 5 minutes. The percentage of time spent exploring the open arms has been proposed
to relate inversely to an anxiety-like state,
whereas the number of arm entries measures general locomotor activity (Pellow, et
al., 1985).
Data Analysis
Data were analyzed using two-way
analysis of variance (ANOVA) with dose
of U-50,488 and dose of nor-BNI as between subjects factors. Further analysis
was performed using the Tukey’s post hoc
test as warranted.
Results
There was a significant interaction between U-50,488 dose and nor-BNI dose
on the percentage of time spent exploring the open arms of the elevated plusmaze (F(1,44) = 6.10, p < 0.05, Figure 1).

Materials and Methods
Animals and Housing
Male Wistar rats (Charles River, Kingston, NY; n=45) weighing 150-200 g upon
arrival were used in this experiment. Rats
were habituated to colony housing 14
days prior to testing. Rats were housed
in groups of 2-3 per cage with food and
water available ad libitum. Rats were handled and weighed daily to minimize any
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Figure 1. Effects of U-50,488 and nor-BNI on percent of time spent on the open arms of the
elevated plus-maze. Rats were pretreated with nor-BNI or vehicle at least 24 hours prior to injection of U-50,488 (0 or 10 mg/kg). Injections of U-50,488 occurred 10 minutes before testing in
the elevated plus-maze. Percent open arm time was calculated as the percent of open arm time /
(open + closed) arm time. * p < 0.05 compared to vehicle, 0 mg/kg U-50,488 group, Tukey’s test.

Figure 2. Effects of U-50,488 and nor-BNI on the percent of open arm entries in the elevated plusmaze. Rats were pretreated with nor-BNI or vehicle at least 24 hours prior to injection of U-50,488
(0 or 10 mg/kg). Injections of U-50,488 occurred 10 minutes before testing in the elevated plusmaze. Percent open arm entries was calculated as the number of open arm entries / (open + closed)
arm entries. Neither U-50,488 or nor-BNI significantly altered the percentage of open arm entries.
the elevated plus-maze. Percent open arm time was calculated as the percent of open arm time /
(open + closed) arm time. * p < 0.05 compared to vehicle, 0 mg/kg U-50,488 group, Tukey’s test.

Rats naturally prefer the enclosed arms of
the maze and spend more time in closed
arms than in the open arms (Pellow, et al.,
1985). Figure 1 illustrates a significant
decrease in the amount of time spent on
the open arms by rats treated with 10 m/
kg of U-50,488 compared to those that
received no treatment. This decrease in
activity caused by U-50,488 indicates an
increase in an anxiety-like state in the rat.
We can conclude that the reversal of the
effects by the kappa opioid antagonist
nor-BNI is not due to a different opioid system, given that nor-BNI has been
shown to exhibit maximum selectivity of
kappa opioid receptors 24 hours after injection (Endoh, et al., 1992). This finding is consistent with previous studies that
have found nor-BNI to reverse the effects
of U-50,488 on the reinforcing efficacy of
cocaine (Mclaughlin, et al., 2003, 2006a,
2006b; Negus, 2004).
The results failed to indicate a significant effect of U-50,488 or nor-BNI on
percent of open arm entries. The percent of open arm entries is thought to be
a measure of anxiety, given that anxiolytic
compounds would be expected to increase
the number of open arm entries without
increasing the exploration of the enclosed
arms (Pellow, et al., 1985). Although we
did not achieve significant results in the
percent of open arm entries, this measurement was not validated to correlate
with other measurements of anxiety, like
the number of arm entries or time spent
on the open arms (Pellow, et al., 1985).

Figure 3. Effects of U-50,488 and nor-BNI on total number of arm entries. Rats were pretreated
with nor-BNI or vehicle at least 24 hours prior to injection of U-50,488 (0 or 10 mg/kg). Injections
of U-50,488 occurred 10 minutes before testing in the elevated plus-maze. * p < 0.05 compared to
vehicle, 10 mg/kg U-50,488 group, Tukey’s test.

Injections of 10 mg/kg U-50,488 significantly decreased percent open arm time
compared to controls, an effect reversed
by pretreatment with 20 mg/kg nor-BNI.
No significant effects of U-50,488 or norBNI on the percentage of open arm entries were found (Figure 2).
A main effect of nor-BNI was found on
the total number of arm entries (F(1,44) =
11.73, p < 0.05, Figure 3). Further analysis revealed that pretreatment with norBNI led to an increased number of arm
entries in rats injected with U-50,488.

Discussion
The principle finding of this study is
that the kappa opioid agonist U-50,488
decreased open arm exploration in the
elevated plus-maze, and this effect was
attenuated by the kappa opioid antagonist nor-BNI. These results suggest that
stress-related behaviors are at least in part
mediated by the activity of the endogenous kappa opioid system.
The time spent exploring the open
arms of the elevated plus-maze can be
considered a measure of emotionality.

The total number of arm entries on
the elevated plus-maze is a measurement
of general locomotor activity of the rat
(Pellow, et al., 1985). Previous research
has suggested that altering kappa opioid
activity can lead to general untoward motor effects (Negus, 2004). Exposure to a
novel environment such as the elevated
plus-maze is in itself anxiogenic and can
result in an increase in time spent immobile (Lister, 1987). Typically, rats exposed
to stress in a novel environment exhibit a
decrease in motor activity and an increase
in anxiety-related behavior, such as freezing or immobility (Pellow, et al., 1985).
However, nor-BNI led to increased locomotion in rats injected with U-50,488,
suggesting that this overall increase in
activity may be a further indication of
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the anxiolytic effects of nor-BNI. The
results revealed a main effect of nor-BNI
on the total number of arm entries in the
elevated plus-maze (Figure 3). If the total number of arm entries is an indicator
of anxiety, then an increase in number of
arm entries would suggest a decrease in
an anxiety-like state in the rat.
In summary, U-50,488 produced
anxiogenic-like properties in rats tested
on the elevated plus-maze. The effects
of U-50,488 were reversed by the kappa
opioid agonist nor-BNI. These results
indicate that the kappa opioid system is
involved in the regulation of anxiety-like
behavior in animals. Understanding the
role of the kappa opioid system in the
regulation of behavioral stress responses
may be crucial in understanding the
mechanisms of stress-related disorders
and provide insight into the potential
therapeutic value of targeting the kappa
opioid system for treatment of anxiety
and other stress-linked disorders.

66
Kappa Opioid Regulation of Stress-Related Behavior
GVSU McNair Scholars Journal

References
Beardsley, P. M., Howard, J. L., Shelton, K. L., & Carroll,
F. I. (2005). Differential effects of the novel kappa
opioid receptor antagonist, JDTic, on reinstatement
of cocaine-seeking induced by footshock stressors vs
cocaine primes and its antidepressant-like effects in rats.
Psychopharmacology, 183, 118-126. doi:10.1007/s00213005-0167-4
Burchfield, S. R. (1979). The stress response: A new
perspective. Psychosomatic Medicine, 41, 661–672.
Retrieved from http://www.psychosomaticmedicine.org/
Chavkin, C., James, I. F., & Goldstein, A. (1982).
Dynorphin is a specific endogenous ligand of the kappa
opioid receptor. Science, 215(4531), 413-415. Retrieved
from http://www.sciencemag.org/
Endoh, T., Matsuura, H., Tanaka, C., & Nagase, H. (1992).
Nor-binaltorphimine: A potent and selective kappaopioid receptor antagonist with long-lasting activity in
vivo. Archives Internationales de Pharmacodynamie et de
Therapie, 316, 30-42.
Hennessy, J. W., & Levine, S. (1979). Stress, arousal,
and the pituitary-adrenal system: A psychoendocrine
hypothesis. In J. M. Sprague & A. N. Epstein (Eds.),
Progress in psychobiology and physiological psychology (8th
ed., pp. 133-178). New York: Academic Press.
Kessler, R., Chiu, W., Demler, O., & Walters, E. (2005).
Prevalence, severity, and comorbidity of twelve-month
DSM-IV disorders in the national comorbidity survey
replication. Archives of General Psychiatry, 62, 617-627.
doi:10.1001/archpsyc.62.6.617
Koob, G.F. (1999). Corticotropin-releasing factor,
norepinephrine and stress. Biological Psychiatry, 46,
1167-1180. doi:10.1016/S0006-3223(99)00164-X
Lister, R. G. (1987). The use of a plus-maze to measure
anxiety in the mouse. Psychopharmacology, 92(2), 180-185.
Retrieved from http://www.springer.com/biomed/
neuroscience/journal/213

McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., &
Chavkin, C. (2006b). Social defeat stress-induced
behavioral responses are mediated by the endogenous
kappa opioid system. Neuropsychopharmacology, 31, 12411248. doi:10.1038/sj.npp.1300872
McLaughlin, J. P., Marton-Popovici, M., & Chavkin,
C. (2003). Kappa opioid receptor antagonism and
prodynorphin gene disruption block stress-induced
behavioral responses. Journal of Neuroscience, 23(13),
5674-5683. Retrieved from http://www.jneurosci.org/
Nabeshima, T., Katoh, A., Wada, M., & Kameyama
T. (1992). Stress-induced changes in brain Metenkephalin, Leu-enkephalin and dynorphin
concentrations. Life Sciences, 51, 211-217.
doi:10.1016/0024-3205(92)90077-3
Negus, Stevens S. (2004). Effects of the kappa opioid
agonist U-50,488 and the kappa opioid antagonist norbinaltorphimine on choice between cocaine and food
in rhesus monkeys. Psychopharmacology, 176, 204-213.
doi:10.1007/s00213-004-1878-7
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985).
Validation of open: closed arm entries in an elevated
plus-maze as a measure of anxiety in the rat. Journal of
Neuroscience Methods, 14, 149-167. doi:10.1016/01650270(85)90031-7
Pellow, S., & File, S. E. (1986). Anxiolytic and anxiogenic
drug effects on exploratory activity in an elevated plusmaze: A novel text of anxiety in the rat. Pharmacology
Biochemistry and Behavior, 24, 525-559. doi:10.1016/00913057(86)90552-6
Selye, H. (1936). A syndrome produced by diverse
nocuous agents. Nature, 138, 32. doi: 10.1038/138032a0
Valdez, G. R., Platt, D. M., Rowlett, J. K., Ruedi-Bettschen,
D., & Spealman, R. D. (2007). Kappa agonist-induced
reinstatement of cocaine seeking in squirrel monkeys: A
role for opioid and stress-related mechanisms. Journal of
Pharmacology and Experimental Therapeutics, 323(2), 525533. doi:10.1124/jpet.107.125484

McLaughlin, J. P., Land, B. B., Li, S., Pintar, J. E., &
Chavkin, C. (2006a). Prior activation of kappa
opioid receptors by U50,488 mimics repeated forced
swim stress to potentiate cocaine place preference
conditioning. Neuropsychopharmacology, 31, 787-794.
doi:10.1038/sj.npp.1300860

67
VOLUME 14, 2010

